Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2005 1
2010 1
2012 1
2016 1
2017 1
2023 4
2024 3
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
CHRONIC POSTOPERATIVE PAIN.
Ladjević N, Milinić M, Jovanović V, Jovičić J, Likić I, Ladjević N. Ladjević N, et al. Acta Clin Croat. 2023 Nov;62(Suppl4):88-96. doi: 10.20471/acc.2023.62.s4.13. Acta Clin Croat. 2023. PMID: 40463450 Free PMC article. Review.
Commonly used drugs to prevent and treat CPNP in the current clinical setting are: opioids, alpha2-adrenergic agonists, cyclooxygenase antagonists, gabapentin, pregabalin, steroids, N-methyl-D-aspartate receptor antagonists and local anesthetics....
Commonly used drugs to prevent and treat CPNP in the current clinical setting are: opioids, alpha2-adrenergic agonists, cyclooxygenase antag …
Diagnosis and Management of Cystic Fibrosis Exacerbations.
Milinic T, McElvaney OJ, Goss CH. Milinic T, et al. Semin Respir Crit Care Med. 2023 Apr;44(2):225-241. doi: 10.1055/s-0042-1760250. Epub 2023 Feb 6. Semin Respir Crit Care Med. 2023. PMID: 36746183 Free PMC article. Review.
Research Coordinators' Perspectives on Recruitment of Minoritized People with Cystic Fibrosis into Clinical Trials.
Milinic T, Burdis N, Gill E, Burks P, Jarosz ME, Hoffman AJ, Kapnadak SG, Ramos KJ, Goss CH. Milinic T, et al. Res Sq [Preprint]. 2024 Nov 13:rs.3.rs-5195002. doi: 10.21203/rs.3.rs-5195002/v1. Res Sq. 2024. Update in: BMC Pulm Med. 2025 Jul 4;25(1):325. doi: 10.1186/s12890-025-03707-9. PMID: 39606463 Free PMC article. Updated. Preprint.
RESULTS: Among 48 respondents, the majority (n = 31, 64%) had little to no experience discussing CF clinical trials with minoritized PwCF. ...
RESULTS: Among 48 respondents, the majority (n = 31, 64%) had little to no experience discussing CF clinical trials with minoritized …
Lung Allocation Score Exceptions in Persons with Cystic Fibrosis Undergoing Lung Transplant.
Bayomy OF, Bradford MC, Milinic T, Kapnadak SG, Morrell ED, Lease ED, Goss CH, Ramos KJ. Bayomy OF, et al. Ann Am Thorac Soc. 2024 Feb;21(2):271-278. doi: 10.1513/AnnalsATS.202306-509OC. Ann Am Thorac Soc. 2024. PMID: 37878995 Free PMC article.
Results: Of 3,538 listings from 3,309 candidates, 2% of listings (n = 81) had at least one exception. Candidates with an exception and those with a risk event but no exception received lung transplants more slowly than people without an exception or risk event (subdistribu …
Results: Of 3,538 listings from 3,309 candidates, 2% of listings (n = 81) had at least one exception. Candidates with an exception an …
A longitudinal analysis of respiratory symptoms in people with cystic fibrosis with advanced lung disease on and off ETI.
Gill ER, Bartlett LE, Milinic T, Burdis N, Pilewski JM, Dunitz JM, Kapnadak SG, Goss CH, Ramos KJ. Gill ER, et al. J Cyst Fibros. 2024 Jan;23(1):161-164. doi: 10.1016/j.jcf.2023.11.008. Epub 2023 Nov 25. J Cyst Fibros. 2024. PMID: 38008684 Free PMC article.

The purpose of this study was to analyze longitudinal changes in respiratory symptoms over 24 months in ETI-treated and untreated PwCF with ALD Symptoms were measured among CF adults with ppFEV(1) < 40% (N = 48, 24 ETI-treated, 24 untreated) using the CFRSD-CRISS and th

…
The purpose of this study was to analyze longitudinal changes in respiratory symptoms over 24 months in ETI-treated and untreated PwCF with …
The role of same-sex mentorship and organizational support in encouraging women to pursue surgery.
Faucett EA, McCrary HC, Milinic T, Hassanzadeh T, Roward SG, Neumayer LA. Faucett EA, et al. Am J Surg. 2017 Oct;214(4):640-644. doi: 10.1016/j.amjsurg.2017.07.005. Epub 2017 Jul 12. Am J Surg. 2017. PMID: 28716310
METHODS: In June of 2016, a survey was sent to medical students at a single institution (n = 472). Questions utilized a 5-point Likert scale. A two-sample t-test was used to evaluate data. ...
METHODS: In June of 2016, a survey was sent to medical students at a single institution (n = 472). Questions utilized a 5-point Liker …
Research coordinators' perspectives on recruitment of minoritized people with cystic fibrosis into clinical trials.
Milinic T, Burdis N, Gill E, Burks P, Jarosz ME, Hoffman AJ, Kapnadak SG, Ramos KJ, Goss CH. Milinic T, et al. BMC Pulm Med. 2025 Jul 4;25(1):325. doi: 10.1186/s12890-025-03707-9. BMC Pulm Med. 2025. PMID: 40615798 Free PMC article.
RESULTS: Among 48 respondents, the majority (n = 31, 64%) had little to no experience discussing CF clinical trials with minoritized PwCF. ...Experienced respondents also identified the importance of having team members who speak the same language or are the same culture a …
RESULTS: Among 48 respondents, the majority (n = 31, 64%) had little to no experience discussing CF clinical trials with minoritized …
[Echohistograms of circumscribed liver lesions].
Jesić R, Grbić R, Kovacević N, Milinić N, Krstić M, Janković G, Pavlović A, Cvejić T. Jesić R, et al. Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):1-4. Srp Arh Celok Lek. 1997. PMID: 17974347 Serbian.
Analysis of echohistographic parameters evidenced the following: mean distribution values of M, Max and N differed in different pathological conditions (Tables 1 and 2). Correlation analysis of the studied parameters revealed different values among the studied groups of pa …
Analysis of echohistographic parameters evidenced the following: mean distribution values of M, Max and N differed in different patho …
13 results